These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
523 related articles for article (PubMed ID: 23993260)
1. Risks of diabetic nephropathy with variation in hemoglobin A1c and fasting plasma glucose. Lin CC; Chen CC; Chen FN; Li CI; Liu CS; Lin WY; Yang SY; Lee CC; Li TC Am J Med; 2013 Nov; 126(11):1017.e1-10. PubMed ID: 23993260 [TBL] [Abstract][Full Text] [Related]
2. Visit-to-visit glycemic variability is a strong predictor of chronic obstructive pulmonary disease in patients with type 2 diabetes mellitus: Competing risk analysis using a national cohort from the Taiwan diabetes study. Chiu HT; Li TC; Li CI; Liu CS; Lin WY; Lin CC PLoS One; 2017; 12(5):e0177184. PubMed ID: 28489885 [TBL] [Abstract][Full Text] [Related]
3. Variation of fasting plasma glucose: a predictor of mortality in patients with type 2 diabetes. Lin CC; Li CI; Yang SY; Liu CS; Chen CC; Fuh MM; Chen W; Li TC Am J Med; 2012 Apr; 125(4):416.e9-18. PubMed ID: 22305579 [TBL] [Abstract][Full Text] [Related]
4. Visit-to-Visit Variations in Fasting Plasma Glucose and HbA Li TC; Yang CP; Tseng ST; Li CI; Liu CS; Lin WY; Hwang KL; Yang SY; Chiang JH; Lin CC Diabetes Care; 2017 Sep; 40(9):1210-1217. PubMed ID: 28705834 [TBL] [Abstract][Full Text] [Related]
5. Annual fasting plasma glucose variation increases risk of cancer incidence and mortality in patients with type 2 diabetes: the Taichung Diabetes Study. Lin CC; Li CI; Liu CS; Lin WY; Chen CC; Yang SY; Lee CC; Li TC Endocr Relat Cancer; 2012 Aug; 19(4):473-83. PubMed ID: 22544890 [TBL] [Abstract][Full Text] [Related]
6. Fasting plasma glucose variability and HbA1c are associated with peripheral artery disease risk in type 2 diabetes. Yang CP; Lin CC; Li CI; Liu CS; Lin CH; Hwang KL; Yang SY; Li TC Cardiovasc Diabetol; 2020 Jan; 19(1):4. PubMed ID: 31910828 [TBL] [Abstract][Full Text] [Related]
7. Visit-to-Visit Glucose Variability Predicts the Development of End-Stage Renal Disease in Type 2 Diabetes: 10-Year Follow-Up of Taiwan Diabetes Study. Yang YF; Li TC; Li CI; Liu CS; Lin WY; Yang SY; Chiang JH; Huang CC; Sung FC; Lin CC Medicine (Baltimore); 2015 Nov; 94(44):e1804. PubMed ID: 26554779 [TBL] [Abstract][Full Text] [Related]
8. Visit-to-visit variability of fasting plasma glucose as predictor of ischemic stroke: competing risk analysis in a national cohort of Taiwan Diabetes Study. Lin CC; Yang CP; Li CI; Liu CS; Chen CC; Lin WY; Hwang KL; Yang SY; Li TC BMC Med; 2014 Sep; 12():165. PubMed ID: 25255837 [TBL] [Abstract][Full Text] [Related]
9. Variability of fasting plasma glucose increased risks of diabetic polyneuropathy in T2DM. Yang CP; Li CI; Liu CS; Lin WY; Hwang KL; Yang SY; Li TC; Lin CC Neurology; 2017 Mar; 88(10):944-951. PubMed ID: 28179465 [TBL] [Abstract][Full Text] [Related]
10. Association between glucose variation and lower extremity amputation incidence in individuals with type 2 diabetes: a nationwide retrospective cohort study. Li CI; Cheng HM; Liu CS; Lin CH; Lin WY; Wang MC; Yang SY; Li TC; Lin CC Diabetologia; 2020 Jan; 63(1):194-205. PubMed ID: 31686118 [TBL] [Abstract][Full Text] [Related]
11. Variability in glycated albumin levels predicts the progression of diabetic nephropathy. Park SB; Kim SS; Kim IJ; Nam YJ; Ahn KH; Kim JH; Jeon YK; Kim BH; Song SH; Kwak IS; Lee EK; Kim YK J Diabetes Complications; 2017 Jun; 31(6):1041-1046. PubMed ID: 28396158 [TBL] [Abstract][Full Text] [Related]
12. Association of Postbreakfast Triglyceride and Visit-to-Visit Annual Variation of Fasting Plasma Glucose with Progression of Diabetic Nephropathy in Patients with Type 2 Diabetes. Kitaoka K; Takenouchi A; Tsuboi A; Fukuo K; Kazumi T J Diabetes Res; 2016; 2016():4351376. PubMed ID: 27975066 [TBL] [Abstract][Full Text] [Related]
13. Study of Irisin Hormone Level in Type 2 Diabetic Patients and Patients with Diabetic Nephropathy. Shelbaya S; Abu Shady MM; Nasr MS; Bekhet MM; Mageed YA; Abbas M Curr Diabetes Rev; 2018; 14(5):481-486. PubMed ID: 28875825 [TBL] [Abstract][Full Text] [Related]
14. Glycated albumin and ratio of glycated albumin to glycated hemoglobin are good indicators of diabetic nephropathy in type 2 diabetes mellitus. Wang N; Xu Z; Han P; Li T Diabetes Metab Res Rev; 2017 Feb; 33(2):. PubMed ID: 27537245 [TBL] [Abstract][Full Text] [Related]
15. Comparative predictive ability of visit-to-visit HbA1c variability measures for microvascular disease risk in type 2 diabetes. Yang CY; Su PF; Hung JY; Ou HT; Kuo S Cardiovasc Diabetol; 2020 Jul; 19(1):105. PubMed ID: 32631323 [TBL] [Abstract][Full Text] [Related]
16. Excessive visit-to-visit glycemic variability independently deteriorates the progression of endothelial and renal dysfunction in patients with type 2 diabetes mellitus. Wei F; Sun X; Zhao Y; Zhang H; Diao Y; Liu Z BMC Nephrol; 2016 Jul; 17(1):67. PubMed ID: 27386849 [TBL] [Abstract][Full Text] [Related]
17. Prognostic association of HbA1c and fasting plasma glucose with reduced kidney function in subjects with and without diabetes mellitus. Results from a population-based cohort study from Germany. Schöttker B; Brenner H; Koenig W; Müller H; Rothenbacher D Prev Med; 2013 Nov; 57(5):596-600. PubMed ID: 23948106 [TBL] [Abstract][Full Text] [Related]
18. Associations of HbA1c and fasting plasma glucose with incident diabetes: Implications for pre-diabetes thresholds in a Japanese population. Nakagami T; Tanaka Y; Oya J; Kurita M; Isago C; Hasegawa Y; Ito A; Hirota N; Tsuzura R; Uchigata Y Prim Care Diabetes; 2016 Dec; 10(6):407-414. PubMed ID: 27515716 [TBL] [Abstract][Full Text] [Related]
19. Visit-to-visit fasting plasma glucose variability is an important risk factor for long-term changes in left cardiac structure and function in patients with type 2 diabetes. Tang X; Zhong J; Zhang H; Luo Y; Liu X; Peng L; Zhang Y; Qian X; Jiang B; Liu J; Li S; Chen Y Cardiovasc Diabetol; 2019 Apr; 18(1):50. PubMed ID: 30992008 [TBL] [Abstract][Full Text] [Related]
20. Visit-to-visit HbA Yang CD; Shen Y; Lu L; Yang ZK; Hu J; Zhang RY; Shen WF; Ding FH; Wang XQ Cardiovasc Diabetol; 2020 Sep; 19(1):133. PubMed ID: 32887588 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]